These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 15113755)

  • 21. Role of invariant natural killer T (iNKT) cells in systemic lupus erythematosus.
    Godó M; Sessler T; Hamar P
    Curr Med Chem; 2008; 15(18):1778-87. PubMed ID: 18691038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Invariant NKT cells regulate experimental autoimmune encephalomyelitis and infiltrate the central nervous system in a CD1d-independent manner.
    Mars LT; Gautron AS; Novak J; Beaudoin L; Diana J; Liblau RS; Lehuen A
    J Immunol; 2008 Aug; 181(4):2321-9. PubMed ID: 18684921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. α-Galactosylceramide suppresses murine eosinophil production through interferon-γ-dependent induction of NO synthase and CD95.
    Gaspar-Elsas MI; Queto T; Masid-de-Brito D; Vieira BM; de Luca B; Cunha FQ; Xavier-Elsas P
    Br J Pharmacol; 2015 Jul; 172(13):3313-25. PubMed ID: 25752588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low density lipoprotein receptor of macrophages facilitates atherosclerotic lesion formation in C57Bl/6 mice.
    Herijgers N; Van Eck M; Groot PH; Hoogerbrugge PM; Van Berkel TJ
    Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):1961-7. PubMed ID: 10938018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD1d-mediated stimulation of natural killer T cells selectively activates hepatic natural killer cells to eliminate experimentally disseminated hepatoma cells in murine liver.
    Miyagi T; Takehara T; Tatsumi T; Kanto T; Suzuki T; Jinushi M; Sugimoto Y; Sasaki Y; Hori M; Hayashi N
    Int J Cancer; 2003 Aug; 106(1):81-9. PubMed ID: 12794761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of high fat diet on NKT cell function and NKT cell-mediated regulation of Th1 responses.
    Miyazaki Y; Iwabuchi K; Iwata D; Miyazaki A; Kon Y; Niino M; Kikuchi S; Yanagawa Y; Kaer LV; Sasaki H; Onoé K
    Scand J Immunol; 2008 Mar; 67(3):230-7. PubMed ID: 18226013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phenotypical and functional alterations during the expansion phase of invariant Valpha14 natural killer T (Valpha14i NKT) cells in mice primed with alpha-galactosylceramide.
    Ikarashi Y; Iizuka A; Koshidaka Y; Heike Y; Takaue Y; Yoshida M; Kronenberg M; Wakasugi H
    Immunology; 2005 Sep; 116(1):30-7. PubMed ID: 16108815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TSLPR deficiency attenuates atherosclerotic lesion development associated with the inhibition of TH17 cells and the promotion of regulator T cells in ApoE-deficient mice.
    Wu C; He S; Peng Y; Kushwaha KK; Lin J; Dong J; Wang B; Lin J; Shan S; Liu J; Huang K; Li D
    J Mol Cell Cardiol; 2014 Nov; 76():33-45. PubMed ID: 25117469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of natural killer T cells by alpha-galactosylceramide in the presence of CD1d provides protection against colitis in mice.
    Saubermann LJ; Beck P; De Jong YP; Pitman RS; Ryan MS; Kim HS; Exley M; Snapper S; Balk SP; Hagen SJ; Kanauchi O; Motoki K; Sakai T; Terhorst C; Koezuka Y; Podolsky DK; Blumberg RS
    Gastroenterology; 2000 Jul; 119(1):119-28. PubMed ID: 10889161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of CD1d under the control of a MHC class Ia promoter skews the development of NKT cells, but not CD8+ T cells.
    Xu H; Chun T; Colmone A; Nguyen H; Wang CR
    J Immunol; 2003 Oct; 171(8):4105-12. PubMed ID: 14530332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NKT cell subsets mediate differential proatherogenic effects in ApoE-/- mice.
    To K; Agrotis A; Besra G; Bobik A; Toh BH
    Arterioscler Thromb Vasc Biol; 2009 May; 29(5):671-7. PubMed ID: 19251589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD1 expression and CD1-restricted T cell activity in normal and tumour-bearing human liver.
    Kenna T; O'Brien M; Hogan AE; Exley MA; Porcelli SA; Hegarty JE; O'Farrelly C; Doherty DG
    Cancer Immunol Immunother; 2007 Apr; 56(4):563-72. PubMed ID: 16924493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ocular immune privilege and CD1d-reactive natural killer T cells.
    Sonoda KH; Stein-Streilein J
    Cornea; 2002 Mar; 21(2 Suppl 1):S33-8. PubMed ID: 11995808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Defining a novel subset of CD1d-dependent type II natural killer T cells using natural killer cell-associated markers.
    Singh AK; Rhost S; Löfbom L; Cardell SL
    Scand J Immunol; 2019 Sep; 90(3):e12794. PubMed ID: 31141185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural killer T cells are required for lipopolysaccharide-mediated enhancement of atherosclerosis in apolipoprotein E-deficient mice.
    Andoh Y; Ogura H; Satoh M; Shimano K; Okuno H; Fujii S; Ishimori N; Eshima K; Tamauchi H; Otani T; Nakai Y; Van Kaer L; Tsutsui H; Onoé K; Iwabuchi K
    Immunobiology; 2013 Apr; 218(4):561-9. PubMed ID: 22954709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of injury-induced suppression of T-cell immunity by the CD1d/NKT cell-specific ligand alpha-galactosylceramide.
    Tulley JM; Palmer JL; Gamelli RL; Faunce DE
    Shock; 2008 Feb; 29(2):269-77. PubMed ID: 17693934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T cell development in mice expressing CD1d directed by a classical MHC class II promoter.
    Forestier C; Park SH; Wei D; Benlagha K; Teyton L; Bendelac A
    J Immunol; 2003 Oct; 171(8):4096-104. PubMed ID: 14530331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of natural killer T cell activation on the initiation of atherosclerosis.
    van Puijvelde GH; van Wanrooij EJ; Hauer AD; de Vos P; van Berkel TJ; Kuiper J
    Thromb Haemost; 2009 Aug; 102(2):223-30. PubMed ID: 19652872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implication of natural killer T cells in atherosclerosis development during a LPS-induced chronic inflammation.
    Ostos MA; Recalde D; Zakin MM; Scott-Algara D
    FEBS Lett; 2002 May; 519(1-3):23-9. PubMed ID: 12023012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD1d-independent NKT cells in beta 2-microglobulin-deficient mice have hybrid phenotype and function of NK and T cells.
    Maeda M; Shadeo A; MacFadyen AM; Takei F
    J Immunol; 2004 May; 172(10):6115-22. PubMed ID: 15128797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.